Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors

	Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors
Source Publication	JOURNAL OF CLINICAL ONCOLOGY
	2020
Volume	38 Issue:15
	Wang Zhenguang; Chen Meixia; Zhang Yan; Liu Yang; Yang Qingming; Nie Jing; Shen Lianjun; Jiang Pengfei; He Jiaping; Ye Xun; Cao Wei; Wang HY(王皓毅); Han Weidong
Document Type	期刊论文
Identifier	http://ir.ioz.ac.cn/handle/000000/14558
Collection	干细胞与生殖生物学国家重点实验室
Recommended Citation GB/T 7714	Wang Zhenguang,Chen Meixia,Zhang Yan,et al. Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors[J]. JOURNAL OF CLINICAL ONCOLOGY,2020,38(15).
APA	Wang Zhenguang.,Chen Meixia.,Zhang Yan.,Liu Yang.,Yang Qingming.,...&Han Weidong.(2020).Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors.JOURNAL OF CLINICAL ONCOLOGY,38(15).
MLA	Wang Zhenguang,et al."Phase I study of CRISPR-engineered CAR-T cells with PD-1 inactivation in treating mesothelin-positive solid tumors".JOURNAL OF CLINICAL ONCOLOGY 38.15(2020).

Related Services

Bookmark

Google Scholar

Similar articles in Bing Scholar

Terms of Use

No data!

Social Bookmark/Share

File name:	Phase I study of CRISPR-engineered CAR-T.pdf
Format:	Adobe PDF

All comments (0)

No comment.

The comment function is only available to registered usersLog In

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Institution:
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh

中国科学院动物研究所机构知识库